We compared the fructosamine activity in sera from healthy and diabetic subjects with the degree of protein glycation detected by a liquid-chromatographic method. The latter technique measures furosine as a specific product after hydrolysis of e-amino-fructose-lysine. Our results indicate that the fructosamine assay measures the extent of glycation of purified human serum albumin correctly. On the other hand, we found no correlation between the two methods for sera from healthy subjects, although for diabetics' sera the values obtained with both methods were related. However, only about half of the reducingactivity (fructosamine) was due to specific nonenzymatic glycation of proteins in healthy subjects and well-controlled diabetics. The remaining unspecific activity varied from serum to serum. It was not reducible with NaBH4 and was independent of the glycation of albumin, which normally accounts for about 80% of glycated serum proteins. The fructosamine assay is therefore of limited specificity for the exact measurement of glycated proteins in serum.
Blood specimens were obtained from all subjects after an overnight fast. All 25 normal controls had Hb A1 values within the normal range (5-8%) and normal results for an oral glucose tolerance test (9) . Sera from 60 unselected patients with type H diabetes were analyzed by both methods. Sera were stored for one or two days at 4 #{176}C before analysis.
Analytical procedures.
We measured Hb A1 with the Boehringer (Mannheim, F.R.G.) assay kit and serum fructosamine with the kit of Hoffmann-La Roche (Basel, Switzerland) in nondialyzed serum specimens.
Glycated serum protein was determined in parallel by the furosine method, with fructose-lysine used for calibration (8) .
In vitro glycations were performed with pled serum from nondiabetics and with human serum albumin (Behring, Marburg, F.R.G.). Protein solutions were incubated at 37 #{176}C in phosphate-buffered saline (PBS) containing 0, 20, 45, 57, 82, or 103 mmol of n-glucose per liter. After 84 h, the samples were dialyzed extensively against PBS. Half of each sample was reduced with 0.5 mg of NaBH4 per milligram of protein and dialyzed for at least 50 h vs PBS (10).
Serum samples from patients were reduced with NaBH4 and NaCN(BH3) and dialyzed as described above. Na(CN)BH3 specifically reduces the aldimine bond, whereas NaBH4 also reduces the keto group of glycated proteins.
Albumin was eliminated by passing the serum samples through a column of Cibacron Blue 3GA according to the manufacturer's instructions (Bio-Rad, Munich, F.R.G.) Electrophoresis of serum protein, performed for all serum samples and all column eluates, showed that more than 95% of the serum albumin content was retainedby the column.
Protein was determined
by the biuret method.
Statistical methods. Linear regression analysis was computed as the principal standardized component by the method proposedby Feldmann etal.(11).
Results
The lysine-bound glucose in pooled serum and in a solution of human serum albumin was determined by the furosine method. Both samples were glycated in vitro to various extents. When these samples were also measured with the fructosamine assay, the extent of glycation, expressed as nanomoles of lys-glu per milligram of protein,2 correlated well with the fructosaimne activity (Figure 1) . Both methods performed well in our laboratory, with CVs of 6.5% and 5.9% for the fructosamine and furosine assays, respectively.
After we reduced the samples with NaBH4, the fructosamine values were no longer dependent on the degree of glycation. Treatment of human serum albumin with NaBH4 yielded a fructosamine activity that was near the detection limit of the assay, but a residual fructosamine activity corresponding to about 0.8 mznol/L was found in the pooled serum samples. After the NaBH4 reduction, this residual reducing activity was different for different sera, ranging from 25% to 60% of the activity before reduction in all serum samples (Table 1 ). In contrast, for all serum samples, furosine values were below the detection limit after reduction with NaBH4. Treatment of the serum samples with Na(CN)BH3 did not change the values measured by the two methods (data not shown). Figure 1 . Glycation of albumin purified from three normal human sera was also measured by both methods. The fructosamine assay gave values of 14-18 nmol of reducing activity per milligram of albumin, corresponding well to the 15 nmol per milligram of albumin reported by Johnson and Baker (3), while the furosine method resulted in 3.1-3.25 nmol of lysglu per milligram of albumin.3 Corrected for the DMFcalibration factor (see above), the two methods gave similar results. Thus, the unspecific activity-i.e., activity not related to the ketoamine linkage-seemed not to be associated with serum albumin. This became also evident when fructosamine activity was measured in albumin-depleted serum:
in terms of nanomoles of reducing activity per milligram of nonalbumin proteins, the values increased ( Table 2 ). The reducing activity of the nonalbumin fraction ranged from 43% to 71% of the total reducing activity, whereas corresponding values for the furosine assay were 9%-22% (Table  2) . Electrophoretic separation and determination of the isolated glycated protein fractions showed that about 80% of total serum glycation is due to albumin (12). All samples had been dialyzed extensively; therefore, the residual unspecific reducing activity in the assay system probably was related to substances of greater molecular mass.
The reference interval for serum for the furosine method is 3.0 ± 0.6 (2 SD) nmol of lys-glu per milligram of protein (12). For sera from 25 healthy subjects we found a range of 31 ± 8.5 (2 SD) for the fructosamine assay. Probably because of the varying degree with which the unspecific reducing components reacted in the fructosamine assay (Table 1) The higher sensitivity of the furosine method-i.e., discrimination between a normal and a diabetic glucose balance-became also evident with respect to Hb A1; 18 of 60 diabetic patients showed normal values for Hb A1. Our results indicate that the fructosamine assay accurately measures the extent of glycation of purified human serum albumin. On the other hand, we have also shown that an unspecific reducing activity in serum, which is not due to protein glycation, is also measured by the fructosamine assay. The interference is not albumin-associated and differs from patient to patient. Evidence that a substantial amount of reducing activity is not albumin- Further indirect evidence that an unspecific reducing activity is measured by the fructosamine assay comes from comparison of the median of 2.37 mmolJL for healthy subjects with a median of 3.02 mmoIiL found for diabetic patients whose median preprandial blood glucose value was 9.3 mmol/L (6). In spite of about twofold increased blood glucose values, their fructosamine activity was increased by only 27%. If fructosamine values were only a result of the specific reducing activity caused by protein glycation, a proportional increase with increasing glucose concentrations would be expected. Because in vitro experiments have shown that nonenzymatic glycation of human serum albumin and other serum protein is proportional to glucose concentration (12, 13), these considerations again support our evidence that measurement of serum fructosamine activity also includes the measurement of a variable unspecific reducing activity. A high index of individuality of fructosamine activity in serum from normal In an earlier publication (12) we showed that glycated serum protein measured by the furosine method is a suitable screening test for diabetes and that it represents a more sensitive measure for long-term control than Hb A1. Both advantages are probably due to the nan-ow reference range and the low individuality in glycated serum protein. On the other hand, the furosine method doesnot replace the glucose tolerance test for diagnosis of impaired glucose tolerance, probably because, in such situations, no significant manifest hyperglycemia is found under normal life conditions. In conclusion: our results indicate that the reducing activity in serum of normal, borderline, or diabetic subjects may be misinterpreted, owing to unspecific component(s). If this influence could be eliminated, the fructosamine assay probably would be a good index to glycated serum proteins.
